Haoxi Health Technology Ltd (HAO) stock

HAONasdaqServices-Advertising AgenciesFiscal year ends June 30

Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Sep 30, 2026Score 4/30

$1.81−0.05 (-2.69%)

Close on Nov 12, 2026Market cap $201.14KP/E –Yield –

Haoxi Health Technology price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Haoxi Health Technology's price to sales ratio was 0.0× on Nov 10, 2026, against 0.1× a year earlier. Over the last 3 years it ranged from 0.0× to 0.3×, with a median of 0.0×.

Price to Sales Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 10, 2026	0.0×	−0.1
2025	Dec 31, 2025	0.1×	+0.1
2024	Dec 31, 2024	0.0×	–

Where these numbers come from

Parsed from the XBRL in Haoxi Health Technology's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-2561 reverse split on Sep 30, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing